Trials / Conditions / Systemic Anaplastic Large Cell Lymphoma
Systemic Anaplastic Large Cell Lymphoma
5 registered clinical trials studyying Systemic Anaplastic Large Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Other NCT06561048 | Corvus Pharmaceuticals, Inc. | Phase 3 |
| Withdrawn | Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma NCT02729961 | University of Washington | Phase 1 / Phase 2 |
| Completed | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma NCT02652715 | Mayo Clinic | N/A |
| Withdrawn | A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib NCT02487316 | Jun Zhu | Phase 4 |
| Completed | A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Adva NCT00585195 | Pfizer | Phase 1 |